Courts Rule Cannabis Companies Face Liability for Capital-Raising Violations

Three Courts Find Cannabis Operators Violated Securities and Lending Rules

Between June 3 and June 27, 2026, courts in California, Massachusetts, and Delaware issued rulings against cannabis companies for capital-raising violations. The California Superior Court ruled that a Los Angeles-based MSO failed to comply with Reg D private placement requirements, ordering disgorgement of $2.1 million raised from 14 investors. The Massachusetts case involved undisclosed related-party loans totaling $1.8 million. Delaware's Chancery Court found a cultivation operator misused $800,000 in investor capital for non-disclosed purposes.

All three cases share a common thread: operators raised capital without adhering to disclosure requirements or used funds outside the scope of offering documents. The rulings come as cannabis companies face tightening credit markets and increased reliance on private placements to fund expansion.

California Court Orders $2.1 Million Disgorgement for Reg D Failures

The California Superior Court ruled on June 3 that Green Horizon Holdings violated Rule 506(c) by failing to verify accredited investor status for 11 of 14 participants in a $2.1 million raise conducted between January and August 2025. Judge Maria Gonzalez found the company relied on investor self-certification without obtaining third-party verification or reviewing financial documents as required under SEC rules.

Green Horizon argued that federal prohibition made traditional verification methods impractical. The court rejected that defense. The ruling ordered full disgorgement plus 8% annual interest, and barred the company from raising capital under Reg D for 24 months. Green Horizon's counsel didn't respond to requests for comment by press time.

Cannabis operators can't use federal illegality as a shield against state securities enforcement, the decision makes clear. California's Department of Financial Protection and Innovation, which brought the case, has opened investigations into at least six other cannabis raises since the ruling.

Massachusetts Ruling Targets Undisclosed Related-Party Loans

On June 18, the Massachusetts Superior Court found that Commonwealth Cannabis Group failed to disclose $1.8 million in loans from entities controlled by two board members, violating both state securities law and the company's operating agreement. The loans, made between March and November 2025, carried interest rates between 12% and 18% — significantly above market rates for similar debt.

Minority investors filed suit in February 2026 after discovering the loans during a routine audit. Judge Robert Chen ruled the loans constituted material related-party transactions requiring advance disclosure and independent valuation. He ordered the company to unwind the loans and pay $340,000 in damages to minority holders.

It's the first ruling in Massachusetts to apply the state's heightened disclosure standard for cannabis companies, enacted in 2024. That statute requires any transaction exceeding $250,000 with an affiliate to undergo independent fairness review.

Delaware Chancery Court Finds Misuse of Investor Capital

The Delaware Court of Chancery ruled June 27 that Emerald Growth LLC diverted $800,000 from a cultivation-facility raise to fund executive compensation and unrelated real estate purchases. Vice Chancellor Lori Will found the company's private placement memorandum explicitly restricted proceeds to "construction, equipment acquisition, and working capital for the Wilmington facility."

Investors discovered the misuse during a 2026 audit after the facility failed to reach commercial production on schedule. CEO Daniel Marks approved $480,000 in bonuses to himself and two executives, the court found, and used $320,000 as a down payment on a residential property in Rehoboth Beach. Marks argued the compensation was "deferred salary" owed from prior years, but the court found no employment agreements supporting that claim.

Will ordered Marks to repay the $800,000 personally. She imposed a five-year bar from serving as an officer or director of any Delaware entity. Emerald Growth filed for Chapter 7 liquidation on July 2.

Industry Faces Tightening Credit and Rising Enforcement Risk

The three rulings arrive as cannabis operators confront a credit crunch driven by rising interest rates and continued federal prohibition. Private placements under Reg D have become the dominant fundraising vehicle, accounting for an estimated 68% of cannabis capital raises in 2025 according to Viridian Capital Advisors. That reliance increases exposure to securities enforcement when operators cut corners on compliance.

State regulators have stepped up scrutiny in parallel. California, Massachusetts, New York, and Illinois have all launched cannabis-focused securities task forces since 2024. The SEC has remained largely absent from cannabis enforcement due to the federal status of the underlying business, leaving state agencies as the primary enforcement mechanism.

For background on capital-raising compliance requirements in cannabis, see the CannIntel topic hub on Cannabis Capital Raising and Compliance.

Operators Must Verify Investors and Document Fund Use

The rulings clarify two non-negotiable compliance requirements for cannabis raises. First, Reg D offerings require objective verification of accredited investor status — self-certification alone doesn't satisfy Rule 506(c). Operators must obtain tax returns, W-2s, brokerage statements, or third-party verification letters. Second, any material related-party transaction must be disclosed in advance and, in jurisdictions like Massachusetts, independently valued.

Fund deployment must match the use-of-proceeds section in offering documents. Courts won't accept after-the-fact rationales for diverting capital, even if the operator claims economic hardship or deferred obligations. Executive compensation not disclosed in the PPM constitutes misuse, the Delaware ruling makes clear, regardless of whether the amounts are commercially reasonable.

Cannabis companies raising capital should engage securities counsel to draft compliant offering documents and establish fund-tracking protocols. The cost of that diligence is a fraction of the disgorgement and reputational damage these three operators now face.

What Operators Should Watch in the Next 90 Days

State regulators in California, Massachusetts, and New York have indicated they'll prioritize cannabis securities enforcement through year-end 2026. Operators who raised capital in 2024 or 2025 should conduct internal audits of investor verification files and fund-use documentation. Any gaps should be remediated before enforcement inquiries begin.

The Massachusetts ruling may prompt other states to adopt similar heightened-disclosure regimes for related-party transactions. Operators in Illinois, Michigan, and New Jersey — states with active cannabis markets and robust securities enforcement — should monitor legislative developments and consult local counsel.

Finally, the Delaware decision sets a precedent for piercing the corporate veil in cannabis misuse cases. Officers and directors can no longer assume limited liability will shield personal assets when investor funds are diverted. D&O insurance carriers are already tightening coverage terms for cannabis clients in response.